Search

Author/Creator Cranmer, Lee

3. A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanoma. Issue 1 (27th July 2018)

Authors:
Clark, Joseph I.; Singh, Jatinder; Ernstoff, Marc S.; Lao, Christopher D.; Flaherty, Lawrence E.; Logan, Theodore F.; Curti, Brendan; Agarwala, Sanjiv S.; Taback, Bret; Cranmer, Lee; Lutzky, Jose; Luna, Theresa L.; Aung, Sandra; Lawson, David H.
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 6:Issue 1(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A multi-center study of high dose Aldesleukin (Proleukin® (HD IL-2) + Vemurafenib Zelboraf® ) therapy in patients with BRAFV600 mutation positive metastatic melanoma (proclivity 01). (6th November 2014)

Authors:
Clark, Joseph; Flaherty, Lawrence; Ernstoff, Marc; Koon, Henry; Milhem, Mohammed; Militello, Gerald; Agarwala, Sanjiv; Curti, Brendan; Cranmer, Lee; Lao, Christopher D; Logan, Theodore F; Lutzky, Jose; Rudrapatna, Venkatesh; Daniels, Gregory; Taback, Bret; Aung, Sandra; Lowder, James; Lawson, David
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 2(2014)Supplement 3
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Characterization of a novel radiation‐induced sarcoma cell line. Issue 6 (2nd February 2015)

Authors:
Lang, Julie; Zhu, Weizhu; Nokes, Brandon; Sheth, Grishma; Novak, Petr; Fuchs, Laura; Watts, George; Futscher, Bernard; Mineyev, Neal; Ring, Alexander; LeBeau, Lauren; Nagle, Ray; Cranmer, Lee
Journal:
Journal of surgical oncology
Issue:
Volume 111:Issue 6(2015:May 01)
Page Start:
669
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma. (November 2016)

Authors:
Schadendorf, Dirk; Dummer, Reinhard; Hauschild, Axel; Robert, Caroline; Hamid, Omid; Daud, Adil; van den Eertwegh, Alfons; Cranmer, Lee; O'Day, Steven; Puzanov, Igor; Schachter, Jacob; Blank, Christian; Salama, April; Loquai, Carmen; Mehnert, Janice M.; Hille, Darcy; Ebbinghaus, Scot; Kang, S. Pe...
Journal:
European journal of cancer
Issue:
Volume 67(2016)
Page Start:
46
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Nab-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors. Issue 33 (20th November 2021)

Authors:
Wagner, Andrew J.; Ravi, Vinod; Riedel, Richard F.; Ganjoo, Kristen; Van Tine, Brian A.; Chugh, Rashmi; Cranmer, Lee; Gordon, Erlinda M.; Hornick, Jason L.; Du, Heng; Grigorian, Berta; Schmid, Anita N.; Hou, Shihe; Harris, Katherine; Kwiatkowski, David J.; Desai, Neil P.; Dickson, Mark A.
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 33(2021)
Page Start:
3660
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Open-label, randomized, multi-center study comparing the sequence of high dose Aldesleukin (Proleukin® (HD IL-2) and Ipilimumab Yervoy® ) in patients with metastatic melanoma (proclivity 02). (6th November 2014)

Authors:
Patel, Sapna; Milhem, Mohammed; Hallmeyer, Sigrun; Daniels, Gregory; Cranmer, Lee; Taback, Bret; Flaherty, Lawrence; Aung, Sandra; Lowder, James; Sharfman, William
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 2(2014)Supplement 3
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗